# A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy

> **NCT03032172** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 174 (actual)

## Conditions studied

- Spinal Muscular Atrophy

## Interventions

- **DRUG:** Risdiplam

## Key facts

- **NCT ID:** NCT03032172
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-03
- **Primary completion:** 2025-02-07
- **Final completion:** 2025-02-07
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03032172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03032172, "A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03032172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*